Key result
CYP2C19 polymorphisms show no significant association with clopidogrel resistance.
Why the study?
CYP2C19 polymorphisms are implicated in clopidogrel resistance but vary by ethnic group and geography, leaving their association unclear in Han and Tibetan populations in Qinghai Province, China.
Are CYP2C19 *2, *3, and *17 polymorphisms associated with clopidogrel resistance in Han and Tibetan patients with coronary heart disease and ischemic stroke?
Cross-Sectional (n=91)
No
Are CYP2C19 *2, *3, and *17 polymorphisms associated with clopidogrel resistance in Han and Tibetan patients with coronary heart disease and ischemic stroke?
Clinical factors including older age, aspirin resistance, and shortened APTT, rather than CYP2C19 genetic variants, were the main drivers of clopidogrel resistance in this Chinese cohort.
Answers are grounded in this paper and cite their sources.
Clinical factors may predominate over CYP2C19 variants in clopidogrel resistance; leaves open causal roles pending prospective validation.
Objective. Clopidogrel is widely used for preventing ischemic complications related to cardiovascular diseases. However, many patients experience clopidogrel resistance (CR). The polymorphisms of CYP2C19 have been implicated in CR, but CYP2C19 polymorphism considerably varies with both ethnic group and geographical location. This study aimed to investigate the association between CYP2C19 polymorphisms and clopidogrel resistance (CR) in patients with coronary heart disease and ischemic stroke among Han and Tibetan populations in Qinghai Province, China. Methods. From June 2019 to January 2020, patients who were diagnosed with coronary heart disease or cerebral infarction in internal medicine of Qinghai Provincial People’s Hospital and had taken dual antiplatelet drugs were included in this study. Blood was collected and routine items were completed. Whole exome sequencing was performed for CYP2C19 genetic polymorphisms of CYP2C19 <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>∗</a:mi> </a:math> 2 (rs4244285), CYP2C19 <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mi>∗</c:mi> </c:math> 3 (rs4986893), and CYP2C19 <e:math xmlns:e="http://www.w3.org/1998/Math/MathML" id="M3"> <e:mi>∗</e:mi> </e:math> 17 (rs12248560). Results. A total of 91 patients with coronary heart disease or cerebral infarction (67 Han people (65.99 ± 12.25 years old) and 24 Tibetan (63.6324 Tib years old)) including 52 cases with CR and 39 cases with non-CR were enrolled in this study. For the Han population, the differences in age, glycosylated hemoglobin, activated partial thromboplastin time (APTT), gender, aspirin resistance, and diabetes were significant between the CR and non-CR groups. For the Tibetan population, the two groups showed no significant difference in all indicators. There was no significant difference between CR and non-CR groups for all genotypes (CYP2C19 <g:math xmlns:g="http://www.w3.org/1998/Math/MathML" id="M4"> <g:mi>∗</g:mi> </g:math> 2, <i:math xmlns:i="http://www.w3.org/1998/Math/MathML" id="M5"> <i:mi>∗</i:mi> </i:math> 3, and <k:math xmlns:k="http://www.w3.org/1998/Math/MathML" id="M6"> <k:mi>∗</k:mi> </k:math> 17) in either Han or Tibetan populations. For the Han populations, age, APTT, and aspirin resistance were significantly correlated with CR. Conclusion. The present study indicated that CYP2C19 <m:math xmlns:m="http://www.w3.org/1998/Math/MathML" id="M7"> <m:mi>∗</m:mi> </m:math> 2, CYP2C19 <o:math xmlns:o="http://www.w3.org/1998/Math/MathML" id="M8"> <o:mi>∗</o:mi> </o:math> 3, and CYP2C19 <q:math xmlns:q="http://www.w3.org/1998/Math/MathML" id="M9"> <q:mi>∗</q:mi> </q:math> 17 alleles were not correlated with CR for both Han and Tibetan populations in Qinghai Province, while age, APTT, and aspirin resistance were independent risk factors of CR in this region.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2022) conducted a cross-sectional in Coronary heart disease and ischemic stroke (n=91). CYP2C19 polymorphisms (*2, *3, and *17) vs. Wild-type/Non-carriers (implicit) was evaluated on Clopidogrel resistance (CR) (p=>0.05). CYP2C19 *2, *3, and *17 alleles were not significantly correlated with clopidogrel resistance, whereas age, APTT, and aspirin resistance were identified as independent risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: